Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Rio Tintos Muster: Erst die Investition, dann die Milliarden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
257 Leser
Artikel bewerten:
(1)

Paragon Consulting Partners Becomes Paragon Health IT, Reflecting a Commitment to Enabling Evidence-Based Transformation of Digital Healthcare Services

Finanznachrichten News

SACRAMENTO, CA / ACCESSWIRE / October 24, 2023 / Paragon Consulting Partners, leaders in diagnostic imaging and healthcare IT strategy and implementation, today announce our official name change to Paragon Health IT.

Paragon Health IT

Paragon Health IT



Paragon is growing. With hundreds of years of collective experience delivering services across the diagnostic imaging as well as the healthcare IT fields, this name change demonstrates our commitment to finding new and innovative ways to address the biggest challenges facing the broader spectrum of healthcare leaders across the continuum of care.

Under the new banner of Paragon Health IT, we will continue to offer our trusted consulting services. Beyond services, Strings, a one-of-a-kind technology developed by Paragon will be broadly leveraged to collect, enrich, and analyze data generated across healthcare applications, medical devices, and data orchestration layers in real-time to enable and deliver clinical workflows, monitor solutions, and improve the delivery of technology to the user. This combination of leading-edge software combined with deep expertise enables healthcare organizations to deliver data at the point-of-care, to inject AI and advanced algorithms into workflows, and to measure, monitor, and drive efficiencies across clinical, operational, and IT resources.

"As Paragon Health IT, we will continue to provide the same unparalleled advisory, consultative, and professional services that our customers have trusted for more than a decade," says Jef Williams, Managing Partner. "This decision enables the process of building partnerships much more streamlined. Now with Strings, our customers will also be able to accelerate innovative initiatives involving point-of-care devices, AI, and other leading-edge technologies to further advance the quality and efficiency of care delivery for their patients."

Paragon Health IT will make its official debut at this year's Radiological Society of North America (RSNA) tradeshow, where Strings will be showcased to highlight how clinical and machine-generated data can be tied together to support a highly flexible array of workflow and application monitoring and optimization. When augmented with the 100+ years of collective clinical, technical, and project management experience of the Paragon team Strings provides a complete, collaborative managed services program that enables organizations of all sizes to harness the value of their data for optimizing and de-risking imaging operations.

About Paragon Health IT:

We are a team of passionate healthcare professionals with more than 100 years of collective clinical, technical, and business leadership experience within the healthcare IT and imaging fields. Each member of the team contributes a unique set of skills that together guide collaborative efforts to unify and improve healthcare delivery alongside our care provider and vendor partners.

By combining our trusted professional services with Strings, a fully managed solution for real-time enterprise imaging workflow, application, and infrastructure monitoring and optimization, we can enable and accelerate your enterprise workflow, data, and imaging initiatives.

Learn more:

www.paragonhealthit.com

Contact Information

Jef Williams
Managing Partner
jef@paragonhealthit.com

SOURCE: Paragon Health IT

.

View source version on accesswire.com:
https://www.accesswire.com/795099/paragon-consulting-partners-becomes-paragon-health-it-reflecting-a-commitment-to-enabling-evidence-based-transformation-of-digital-healthcare-services

© 2023 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.